echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Lancet: Study on Alzheimer's biomarker characteristics in patients with Down syndrome

    Lancet: Study on Alzheimer's biomarker characteristics in patients with Down syndrome

    • Last Update: 2020-07-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Alzheimer's disease and its complications are the leading cause of death in adults with Down syndrome, and researchers recently examined how Alzheimer's biomarkers change in adult populations with Down syndromestudies were conducted in Spain and the United Kingdom and classified the cognitive status of the patients involved in the study according to CAMCOG-DS, who were with mild and moderate disabilities and could receive Alzheimer's biomarker assays, with the main endpoint being the sequence and age of changes in biomarkers388 people with Down syndrome participated in the study, of which 257 (66%) were asymptomatic, 48 (12%) had pre-ire Alzheimer's disease, 83 (21%) had Alzheimer's disease, and 242 control groups were recruitedThe study found that from the age of 30, People with Down syndrome began to change in CSF A beta 1-42/1-40 and plasma NFL levels; The average age at which Alzheimer's disease is diagnosed is 50.2 years, and Alzheimer's disease is 53.7 yearsThe prevalence of symptomatic Alzheimer's disease increases with age, with almost 90-100% of the disease at age 70Alzheimer's disease has a long preclinical stage in patients with Down syndrome, during which biomarkers follow a predictable sequence of changes for up to 20 years
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.